EVIS LUCERA GASTROINTESTINAL VIDEOSCOPE GIF-Q260J

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,literature,user facil report with the FDA on 2020-02-17 for EVIS LUCERA GASTROINTESTINAL VIDEOSCOPE GIF-Q260J manufactured by Olympus Medical Systems Corp..

Event Text Entries

[184288964] The subject device was not returned to olympus medical systems corp (omsc). Omsc could not review the service and manufacturing record because the serial number was not provided from the facility. The malfunction of the subject device concerning this case has not been reported. The exact cause could not be determined. If additional information becomes available, this report will be supplemented.
Patient Sequence No: 1, Text Type: N, H10


[184288965] Olympus medical systems corp. (omsc) received a literature titled? Neurological symptoms and spinal cord embolism caused by endoscopic injection sclerotherapy for esophageal varices?. The following is a summary of the literature: the patient who had (b)(6) had the ligation treatment of esophageal and gastric varices with tissue glue injection under intravenous anesthesia. Olympus single use injector model nm-400l-0423 and gastrointestinal videoscope model gif-q260j were used for the procedures. The procedure was completed and the patient returned to the hospital ward. Six hours after the procedure, the patient complained of the weakness and numbness in the lower limbs, abdominal distension and slight dysuresia. The patient's vital signs were stable, lower extremities were normal, the right limb muscle strength was iv level, and bilateral babinski signs were positive. The patient had magnetic resonance imaging (mri) of the thoracic and lumbar spine within twelve hours postoperation and spinal cord embolism was detected. Therefore, the facility stopped the hemostatic and coagulation regimen immediately and started nerve nourishment and microcirculation therapies, along with dexamethasone injections. Three months after this treatment, cervical and thoracic mri did not show any embolism in the spinal cord. The user states in the literature that spinal cord embolism is rare complication of endoscopic injection sclerotherapy. Based on the available information, a direct relationship between the olympus product and the observed adverse events could not be determined. Therefore, omsc will submit 2 medical device reports depending on the number of device. This report is a report of gif-q260j.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010047-2020-01362
MDR Report Key9716154
Report SourceFOREIGN,LITERATURE,USER FACIL
Date Received2020-02-17
Date of Report2020-02-17
Date Mfgr Received2020-01-29
Date Added to Maude2020-02-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR KAZUTAKA MATSUMOTO
Manufacturer Street2951 ISHIKAWA-CHO
Manufacturer CityHACHIOJI-SHI, TOKYO-TO 192-8507
Manufacturer CountryJA
Manufacturer Postal192-8507
Manufacturer Phone426425177
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEVIS LUCERA GASTROINTESTINAL VIDEOSCOPE
Generic NameGASTROINTESTINAL VIDEOSCOPE
Product CodeFDS
Date Received2020-02-17
Model NumberGIF-Q260J
Device Availability*
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerOLYMPUS MEDICAL SYSTEMS CORP.
Manufacturer Address2951 ISHIKAWA-CHO HACHIOJI-SHI, TOKYO-TO 192-8507 JA 192-8507


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-02-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.